You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 292 No. 14, October 13, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Research Letters
 This Article
 •Extract
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Neurology
 •Genetic Disorders
 •Alert me on articles by topic

Premutation Alleles Associated With Parkinson Disease and Essential Tremor

To the Editor: There is evidence that older male carriers of premutation alleles (55-200 CGG repeats) of the fragile X mental retardation 1 (FMR1) gene are at high risk of developing the fragile X–associated tremor/ataxia syndrome1 and spinocerebellar ataxia.2 Since the phenotypes associated with these disorders overlap with those of Parkinson disease (PD) and essential tremor, we sought to determine the prevalence of FMR1 premutation alleles in men with these movement disorders.

Methods

From our DNA bank we conducted FMR1 premutation analysis in 216 men with idiopathic PD excluding atypical cases (mean age at symptom onset, 56.3 [SD, 12.2] years) and in 196 male patients with typical essential tremor (mean age at symptom onset, 53.7 [SD, 14.3] years). Genomic DNA was isolated from peripheral blood and amplification of DNA was carried out using the GC-RICH polymerase chain reaction System (Roche Diagnostics, Indianapolis, Ind). The CGG repeats were detected on 6% denatured polyacrylamide gel, and nucleotide sequencing was performed by an automated DNA sequencer (ABI PRISM 3100) from purified polymerase chain reaction products. Written informed consent, approved by the Baylor College of Medicine institutional review board, was obtained from all participants.


Results

Using sampling from a binomial distribution, the expected frequency of premutation of FMR1 was less than 2% in PD and essential tremor with 95% confidence. We did not detect CGG premutation in any of the 412 X chromosomes of patients with PD and essential tremor. There were 31 distinct alleles, ranging from 13 to 51 CGG repeats. Four of 216 patients (1.9%) with PD and 3 of 196 patients (1.5%) with essential tremor had alleles with CGG repeats falling within the "gray zone" of 45 to 54 CGG repeats as defined by the American College of Medical Genetics,3 with maximum CGG repeats of 51 found in 1 patient with PD and 47 found in 1 patient with essential tremor. Patients in this range cannot be differentiated from others by clinical features, and the frequency of 45 to 54 CGG repeats in these patients is not different from that in normal controls.4 We also confirmed a premutation (55 CGG repeats) in a 38-year-old African American patient with parkinsonism and dementia from a Huntington disease–like 2 (HDL2) pedigree,5 the first report of coexistence of the premutation of FMR1 with the lowest end and trinucleotide repeats expansion (57 CTG/CAG repeats) of JPH3 (HDL2) in the same patient, while a family member with full mutation of FMR1 and trinucleotide expansion of JPH3 showed no symptom of parkinsonism.


Comment

Premutation of the FMR1 gene in men is associated with various movement disorders, including tremor, ataxia, and parkinsonism, that have clinical features overlapping with PD and essential tremor.1, 6 We sought premutations in men with PD and in those with essential tremor to determine whether these 2 disorders are pathogenetically related to this genetic abnormality, but we found no FMR1 premutation in our population of patients with PD and essential tremor. This is consistent with other reports indicating lack of FMR1 premutation in patients with essential tremor,7-8 atypical parkinsonism, and ataxias.8 Thus, premutation of FMR1 probably plays little or no role in the pathogenesis of idiopathic PD or essential tremor. Furthermore, it is unlikely that this genetic abnormality accounts for the male preponderance in patients with PD.9

Access to Data: All of the authors had full access to the data in the study and take responsibility for the integrity of the data and the accuracy of the data analyses.

Funding /Support: This work was supported by National Institute of Neurological Disorders and Stroke grant 043567.

Role of the Sponsor: The National Institute of Neurological Disorders and Stroke had no role in the design and conduct of the study; the collection, interpretation, and analysis of the data; the preparation of the data; or the preparation, review, or approval of the manuscript.

Hao Deng, PhD; Weidong Le, MD, PhD; Joseph Jankovic, MD
josephj{at}bcm.tmc.edu
Parkinson Disease Center and Movement Disorders Clinic
Department of Neurology
Baylor College of Medicine
Houston, Tex

1. Jacquemont S, Hagerman RJ, Leehey MA, et al. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA. 2004;291:460-469. FREE FULL TEXT
2. Macpherson J, Waghorn A, Hammans S, Jacobs P. Observation of an excess of fragile-X premutations in a population of males referred with spinocerebellar ataxia. Hum Genet. 2003;112:619-620. ISI | PUBMED
3. Maddalena A, Richards CS, McGinniss MJ, et al. Technical standards and guidelines for fragile X: the first of a series of disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics. Quality Assurance Subcommittee of the Laboratory Practice Committee. Genet Med. 2001;3:200-205. PUBMED
4. Brown WT, Nolin S, Houck G Jr, et al. Prenatal diagnosis and carrier screening for fragile X by PCR. Am J Med Genet. 1996;64:191-195. FULL TEXT | PUBMED
5. Walker RH, Jankovic J, O'Hearn E, Margolis RL. Phenotypic features of Huntington's disease-like 2. Mov Disord. 2003;18:1527-1530. PUBMED
6. Hagerman RJ, Leehey M, Heinrichs W, et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology. 2001;57:127-130. FREE FULL TEXT
7. Garcia Arocena D, Louis ED, Tassone F, et al. Screen for expanded FMR1 alleles in patients with essential tremor. Mov Disord. 2004;19:930-933. FULL TEXT | ISI | PUBMED
8. Tan EK, Zhao Y, Puong KY, et al. Fragile X premutation alleles in SCA, ET, and parkinsonism in an Asian cohort. Neurology. 2004;63:362-363. FREE FULL TEXT
9. Wooten GF, Currie LJ, Bovbjerg VE, Lee JK, Patrie J. Are men at greater risk for Parkinson's disease than women? J Neurol Neurosurg Psychiatry. 2004;75:637-639. FREE FULL TEXT

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2004;292:1685-1686.


RELATED ARTICLE

Proxy decision making for incompetent patients. An ethical and empirical analysis
E. J. Emanuel and L. L. Emanuel
JAMA. 1992;267(15):2067-2071.
 


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Screen for Excess FMR1 Premutation Alleles Among Males With Parkinsonism
Kraff et al.
Arch Neurol 2007;64:1002-1006.
ABSTRACT | FULL TEXT  

Genetics of essential tremor
Deng et al.
Brain 2007;130:1456-1464.
ABSTRACT | FULL TEXT  

Elderly-onset essential tremor is associated with dementia
Munhoz et al.
Neurology 2007;68:242-243.
FULL TEXT  

Size bias of fragile X premutation alleles in late-onset movement disorders
Jacquemont et al.
J. Med. Genet. 2006;43:804-809.
ABSTRACT | FULL TEXT  

Genomewide scans in North American families reveal genetic linkage of essential tremor to a region on chromosome 6p23
Shatunov et al.
Brain 2006;129:2318-2331.
ABSTRACT | FULL TEXT  

Extended study of A265G variant of HS1BP3 in essential tremor and Parkinson disease
Deng et al.
Neurology 2005;65:651-652.
FULL TEXT  

Premutation Alleles and Fragile X-Associated Tremor/Ataxia Syndrome
Toft and Farrer
JAMA 2005;293:296-296.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.